Cover Image
市場調查報告書

全球醫藥品、醫療產業 (季度更新報告)

Global Pharmaceuticals and Healthcare Report Q1 2017

出版商 BMI Research 商品編碼 363590
出版日期 內容資訊 英文 35 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球醫藥品、醫療產業 (季度更新報告) Global Pharmaceuticals and Healthcare Report Q1 2017
出版日期: 2017年02月08日 內容資訊: 英文 35 Pages
簡介

本報告提供全球製藥產業及醫療產業相關分析,全球整體的產業規模的實際成果值、預測值 (過去5年、今後10年份) 估計,產業抱的課題 (風險) 和未來性的商機 (利潤) 相關評估,主要企業簡介等資訊彙整,為您概述為以下內容。

BMI產業分析

  • 全球市場的最新形勢

SWOT分析

  • 全球市場的最新形勢

產業預測

  • 醫藥品市場最新形勢
  • 醫療市場最新形勢

產業的風險/利潤指標

  • 全球:風險/利潤指標

市場概況

  • 全球市場的最新形勢

產業的趨勢與發展

  • 全球市場的最新形勢

全球市場概況

  • 全球市場的最新形勢

詞彙表

分析方法

  • 醫藥品支出額的預測模式
  • 醫療費的預測模式
  • 分析方法的相關註記
  • 風險/利潤指標技術
  • 指標概要
  • 指標的加權

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 2398-1008

BMI View: Pharmaceutical companies will face an increasing number of external risks to their operations. Many of these new challenges emanate from the global financial crisis of 2007-2008. In an era of fiscal pressures, governments are seeking to control growth in healthcare spending and will disproportionately target expenditure on medicines with mechanisms such as pharmacoeconomics. The key internal business risk for drugmakers will remain the failure of product candidates in late-stage clinical trials.

Headline Expenditure Projections

  • The USD1,071bn (EUR965bn) global pharmaceutical market is forecast to post a 4.6% compound annual growth rate (CAGR) through to 2020.
  • The USD7,356bn (EUR6,633bn) global healthcare market is forecast to post a 5.0% CAGR through to 2020.

Note: Growth forecasts are in local currency terms that are aggregated from the country-level US dollar proportions, which have been equalised to minimise currency fluctuations using a time series-weighted calculation.

Risk/Reward Index

The global pharmaceutical market has a Risk/Reward Index (RRI) score of 50.1 out of 100 in Q117 (down from 51.0 in Q416). With a score of 58.4 (down from 60.2 in Q416), Europe is the leading region, followed by Asia Pacific (51.2; down from 52.4 in Q416), the Americas (50.6; up from 50.5 in Q316), the Middle East & North Africa (48.1; down from 48.8 in Q316) and Sub-Saharan Africa (32.5; down from 33.0 in Q316).

Table of Contents

BMI Industry View

  • Table: Headline Pharmaceuticals & Healthcare Forecasts (Global 2014-2020)

SWOT

  • Global SWOT
  • Industry Forecast
  • Global Pharmaceutical Market Forecast
    • Table: Pharmaceutical Sales, Historical Data And Forecasts (Global 2012-2020)
  • Global Healthcare Market Forecast
    • Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Global 2012-2020)

Industry Risk Reward Index

  • Global Risk/Reward Index

Market Overview

  • Global Pharmaceuticals & Healthcare Market Overview

Industry Trend Analysis

  • Global Themes
    • Table: Biosimilars Approved In The EU To October 2016

Industry Trends & Developments

  • Global Pharmaceuticals & Healthcare Round-Up, Q117
    • Table: Global Pharmaceutical Market

Glossary

Methodology

  • Pharmaceutical Expenditure Forecast Model
  • Healthcare Expenditure Forecast Model
  • Notes On Methodology
  • Risk/Reward Index Methodology
  • Index Overview
    • Table: Pharmaceutical Risk/Reward Index Indicators
  • Indicator Weightings
Back to Top